UB657
TargetsROR1
IndicationsNon-Hodgkin's lymphoma; Breast cancer; Ovarian cancer
ClinicalCN - I
TherapeuticsOncology
ModalitiesADC
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →